Quiz: Evolving Treatment Options in BRAF V600E Mutant Metastatic Colorectal Cancer

Quiz: Evolving Treatment Options in BRAF V600E Mutant Metastatic Colorectal Cancer

April 17, 2020

In our gastrointestinal cancer quiz, you’ll get a chance to test your knowledge on the BRAF V600E mutation in patients with colorectal cancer.

In our gastrointestinal cancer quiz, you’ll get a chance to test your knowledge on the BRAF V600E mutation in patients with colorectal cancer. Here’s your first question:

1. What combination treatment was studied in the BEACON CRC study of patients with BRAF V600E mutated metastatic colorectal cancer?

A. Encorafenib (Braftovi), cetuximab (Erbitux), and binimetinib (Mektovi)

B. Vemurafenib (Zelboraf), dabrafenib, and trametinib

C. Dabrafenib, cetuximab, and encorafenib

D. Vemurafenib, trametinib, and binimetinib